この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1999/8/61 分で読めます
Implantation and Injectable Dosage Form New Animal Drugs; Oxytetracycline Injection; Technical Amendment
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending the animal drug regulations to include a limitation in the approval of Pliva d.d.'s abbreviated new animal drug application (ANADA). The regulation did not state that use of Pliva d.d.'s oxytetracycline injection in cattle is limited to use in nonlactating dairy cattle. At this time, the regulation is amended to reflect the limitation.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →